BioSpace News Archive

Neogen Corporation (Nasdaq: NEOG) announced today that Health Canada has granted temporary approval for Neogen to supply Neogen® Viroxide Super disinfectant to aid in the country’s fight against COVID-19.

Oncosec Medical Incorporated (the “Company” or “Oncosec”) (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced published data in Clinical Cancer Research, linked here, that demonstrated its lead product candidate, TAVO™ (interleukin-12 or “IL-12" plasmid), in combination with the anti-PD-1 checkpoint inhibitor KEYTRUDA

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced financial results for the three months ended March 31, 2020 and highlighted recent corporate updates.

The Galien Foundation announced today upcoming events throughout the year, including the annual Galien Forum and Prix Galien USA Ceremony, the biennial Prix Galien International, the inaugural Prix Galien Africa and the Prix Galien Golden Jubilee, which culminates the Foundation’s 50 years of celebration of innovation across the globe.

DongWha Pharm (KRX:000020), a leading Korean pharmaceutical company, announced on April 21 st , 2020 that it plans to conduct clinical trials using a new drug candidate DW2008 to treat COVID-19. DW2008 is an extract of the water willow plant ( Justicia procumbens ). In vitro antiviral experiments performed at the Institut Pasteur Korea against COVID-19 demonstrate

Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that Institutional Shareholder Services Inc. (ISS) and Glass Lewis, two leading independent research and proxy advisory firms that provide institutional investors with voting assessment and recommendations based on evaluating governance, business, legal, political and accounting risks at public companies,

Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report its first quarter 2020 financial and operating results following the close of U.S. financial markets on Monday, May 11, 2020. Conference call details are as follows: Date: May 11, 2020 Time: 4:30 p.m. U.S. Eastern Time (ET) Dial-in number: (877)

Boston Scientific Corporation (NYSE: BSX) will participate in three upcoming virtual investor conferences. On May 13, 2020 , Dan Brennan , executive vice president and chief financial officer,

Analysis Group , a global leader in health economics and outcomes research (HEOR), announced the publication of the first study to quantitatively assess the efficacy and safety evidence of current and emerging treatments for patients with non-muscle-invasive bladder cancer (NMIBC) whose cancer recurred following treatment with Bacillus Calmette

The COVID-19 pandemic is an unprecedented global health crisis, impacting all aspects of life and society.